A Study Evaluating the Safety and Efficacy of QGE031 in Atopic Dermatitis Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
The study will assess the safety and efficacy of QGE031 in the treatment of moderate to severe atopic dermatitis patients. In addition, QGE031 levels in the blood will be measured and the effect of QGE031 on markers in the blood and skin will be evaluated. Comparisons of the effect of QGE31 will be made with placebo and also cyclosporine, a treatment already established as being effective in atopic dermatitis.
Epistemonikos ID: 59e7cf75d1fff240dad7eebd5aa44adc3e897787
First added on: May 10, 2024